Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,396.08
(
-1.25%
)
US TECH 100
22,654.00
(
-1.30%
)
Dow Jones
45,393.73
(
-1.23%
)
Brent Oil
104.88
(
4.18%
)
Bitcoin
65,870.01
(
-4.24%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: spartex post# 28827

Wednesday, 05/17/2006 4:49:41 PM

Wednesday, May 17, 2006 4:49:41 PM

Post# of 257295
>Just grabbed some REGN at 12.28.<

I’m paying closer attention to REGN after their recent excellent (but early) data with the intravitreal formulation of VEGF-Trap for AMD (#msg-10907088). If those data hold up, VEGF-Trap could be a serious competitor to Lucentis. They still have a long way to go, of course.

A possible driver for REGN’s stock price is a re-partnering of ophthalmic VEGF-Trap on lucrative terms, which would make SNY look really dumb for dropping the program.

Comments?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today